IDT Biologika GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:IDT Biologika GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014192
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a manufacturer of vaccines and bio-pharmaceuticals products. It offers services which include integrated development and manufacturing services in four major areas of animal health, vaccines, pharmaceuticals and quality control. The company develops, manufactures and markets pharmaceutical products such as sterile, injectable and bio-engineered finished products. IDT Biologika handles manufacturing and quality control processes which include bulk active substances, sterile filling, packaging systems, cold chains, early development, small-batch production of samples and large-scale production. It has operational presence in the US and Germany. The company partners with biotechnology and pharmaceutical companies. IDT Biologika is headquartered in Dessau-Rosslau, Germany.

IDT Biologika GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Biologika GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 10
IDT Biologika Acquiers Animal Health Division from Riemser Pharma 11
Partnerships 12
CMC Biologics and IDT Biologika Enter into Agreement 12
Friedrich-Loeffler-Institut Enters into Collaboration Agreement with IDT Biologika 13
Acquisition 14
IDT Biologika to Acquire Gallant Custom Labs 14
IDT Biologika GmbH – Key Competitors 15
IDT Biologika GmbH – Key Employees 16
IDT Biologika GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Nov 02, 2016: Process Development Laboratory opens in the ZENIT building in Magdeburg, Germany 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Key Facts 2
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Biologika GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Biologika GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Biologika GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 10
IDT Biologika Acquiers Animal Health Division from Riemser Pharma 11
CMC Biologics and IDT Biologika Enter into Agreement 12
Friedrich-Loeffler-Institut Enters into Collaboration Agreement with IDT Biologika 13
IDT Biologika to Acquire Gallant Custom Labs 14
IDT Biologika GmbH, Key Competitors 15
IDT Biologika GmbH, Key Employees 16
IDT Biologika GmbH, Subsidiaries 17

★海外企業調査レポート[IDT Biologika GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …
  • China Shenhua Energy Co Ltd:企業のM&A・事業提携・投資動向
    China Shenhua Energy Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Shenhua Energy Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Autoliv, Inc.:企業の戦略・SWOT・財務分析
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Konami Holdings Corp:企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, …
  • Marshall of Cambridge (Holdings) Ltd:戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SMBC Consumer Finance Co Ltd:企業の戦略・SWOT・財務情報
    SMBC Consumer Finance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SMBC Consumer Finance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rice University-製薬・医療分野:企業M&A・提携分析
    Summary Rice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, mi …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for di …
  • Brooks Automation Inc (BRKS):企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Liberty Media Corp (LSTZA):企業の財務・戦略的SWOT分析
    Liberty Media Corp (LSTZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CIMB Private Banking:企業の戦略・SWOT・財務情報
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Commercial Bank Of Ceylon Plc:企業の戦略・SWOT・財務分析
    Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Pentagon Federal Credit Union:企業の戦略的SWOT分析
    Pentagon Federal Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PathoQuest SAS:医療機器:M&Aディール及び事業提携情報
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that provides game changing metagenomics approach to improve the breadth of pathogen detection. The company provides automated bioinformatics software that offers comprehensive pathogens database to produce microbiome reports. Its testin …
  • British Gas Ltd-エネルギー分野:企業M&A・提携分析
    Summary British Gas Limited (British Gas), a subsidiary of Centrica plc, is an energy utility company that undertakes the distribution of gas and electricity. It supplies electricity and gas to residential retail; commercial wholesale; and small, medium and large industrial customers. The company al …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆